Amgen And CytomX Therapeutics Announce Strategic Collaboration In Immuno-Oncology
Go back to Amgen And CytomX Therapeutics Announce Strategic Collaboration In Immuno-Oncology| Amgen Inc (NASDAQ: AMGN) | Delayed: 439.33 +5.60 (1.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $433.73 | 52 Week High | $176.85 | |||
| Open | $431.72 | 52 Week Low | $133.64 | |||
| Day High | $440.51 | P/E | 66.16 | |||
| Day Low | $429.38 | EPS | $6.64 | |||
| Volume | 2,114,678 | |||||
| Eaton Vance Dividend Builder Fd Cl C (NASDAQ: CTMX) | Delayed: 3.28 -0.01 (0.3%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.29 | 52 Week High | $24.68 | |||
| Open | $3.31 | 52 Week Low | $9.10 | |||
| Day High | $3.42 | P/E | N/A | |||
| Day Low | $3.27 | EPS | $0.00 | |||
| Volume | 2,894,720 | |||||
